These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 18084854)

  • 1. Newer antipsychotics and the differences between clinical experiences and clinical trials. Interview by Norman Sussman, MD.
    Marder SR
    CNS Spectr; 2007 Nov; 12(11):812-5. PubMed ID: 18084854
    [No Abstract]   [Full Text] [Related]  

  • 2. An interview with Jeffrey A. Lieberman: Tardive Dyskinesia. [interview by Sussman Norman].
    Lieberman JA
    CNS Spectr; 2007 Oct; 12(10):747-50. PubMed ID: 18018327
    [No Abstract]   [Full Text] [Related]  

  • 3. The debate about the antipsychotics.
    Thomas SP
    Issues Ment Health Nurs; 2004 Mar; 25(2):113-4. PubMed ID: 14726265
    [No Abstract]   [Full Text] [Related]  

  • 4. An interview with Andrew Nierenberg, MD: insight into the Sequenced Treatment Alternatives to Relieve Depression Study by Norman Sussman.
    Nierenberg A
    CNS Spectr; 2007 Dec; 12(12):898-901. PubMed ID: 18229430
    [No Abstract]   [Full Text] [Related]  

  • 5. The neuropharmacology of psychosis.
    Tamminga CA; Davis JM
    Schizophr Bull; 2007 Jul; 33(4):937-46. PubMed ID: 17562697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interview with Darrel A. Regier. The developmental process for the diagnostic and statistical manual of mental disorders, fifth edition. Interview by Norman Sussman.
    Regier D
    CNS Spectr; 2008 Feb; 13(2):120-4. PubMed ID: 18354875
    [No Abstract]   [Full Text] [Related]  

  • 7. Incorporating clinical monitoring into electronic orders for antipsychotics.
    Roche-Desilets J; Fuller MA; Konicki PE
    Psychiatr Serv; 2004 Apr; 55(4):455. PubMed ID: 15067165
    [No Abstract]   [Full Text] [Related]  

  • 8. First- and second-generation antipsychotics.
    McEvoy JP; Zigman D; Margolese HC
    Can J Psychiatry; 2010 Mar; 55(3):144-8; discussion 148-9. PubMed ID: 20370964
    [No Abstract]   [Full Text] [Related]  

  • 9. [Pro and contra: basic precedence of atypical neuroleptics].
    Naber D; Dose M
    Psychiatr Prax; 2005 May; 32(4):163-6. PubMed ID: 15852207
    [No Abstract]   [Full Text] [Related]  

  • 10. Antipsychotics and risk of diabetes in schizophrenia.
    Smith M; Porter R
    Br J Psychiatry; 2009 Feb; 194(2):186-7; author reply 187. PubMed ID: 19182189
    [No Abstract]   [Full Text] [Related]  

  • 11. [New "atypical" neuroleptics -- the emperor's new clothes?].
    Dose M
    Psychiatr Prax; 2003 Jan; 30(1):1-3. PubMed ID: 12524575
    [No Abstract]   [Full Text] [Related]  

  • 12. Atypical antipsychotics: new drugs, new challenges.
    Mathews M; Muzina DJ
    Cleve Clin J Med; 2007 Aug; 74(8):597-606. PubMed ID: 17708131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Drug treatment of functional psychotic disorders].
    Bridler R; Umbricht D; Hell D
    Praxis (Bern 1994); 2001 May; 90(22):981-6. PubMed ID: 11450186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetes, psychotic disorders and antipsychotic therapy: a consensus statement.
    Firestone A
    Med J Aust; 2005 Mar; 182(6):310; author reply 310. PubMed ID: 15777154
    [No Abstract]   [Full Text] [Related]  

  • 15. Antipsychotics in anxiety disorders: an oxymoron or a reflection of non-adequate nomenclature?
    Zohar J; Allgulander C
    Eur Neuropsychopharmacol; 2011 Jun; 21(6):427-8. PubMed ID: 21439795
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparing safety and tolerability of antipsychotic treatment.
    Newcomer JW; Lieberman JA
    J Clin Psychiatry; 2007 Mar; 68(3):e07. PubMed ID: 17388701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A rational approach to the use of atypical antipsychotics.
    Belmaker RH; Bersudsky Y
    Isr J Psychiatry Relat Sci; 2003; 40(2):79-81. PubMed ID: 14509197
    [No Abstract]   [Full Text] [Related]  

  • 18. Second-generation antipsychotics: discrepancies between licensed indications, evidence base and actual use.
    Fleischhacker WW;
    Psychopharmacology (Berl); 2003 Sep; 169(2):207-10. PubMed ID: 12761608
    [No Abstract]   [Full Text] [Related]  

  • 19. Persisting low use of antipsychotics in the treatment of major depressive disorder with psychotic features.
    Andreescu C; Mulsant BH; Peasley-Miklus C; Rothschild AJ; Flint AJ; Heo M; Caswell M; Whyte EM; Meyers BS;
    J Clin Psychiatry; 2007 Feb; 68(2):194-200. PubMed ID: 17335316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The discoverers of the therapeutic effect of chlorpromazine in psychiatry: qui étaient les vrais premiers praticiens?
    Shen WW; Giesler MC
    Can J Psychiatry; 1998 May; 43(4):423-4. PubMed ID: 9598287
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.